Mesentier-Louro L, Goldman C, Ndayisaba A, Buonfiglioli A, Rooklin R, Schuldt B
bioRxiv. 2025; .
PMID: 39975381
PMC: 11839026.
DOI: 10.1101/2025.02.09.637107.
Kon T, Ichimata S, Di Luca D, Martinez-Valbuena I, Kim A, Yoshida K
Brain Commun. 2024; 6(3):fcae141.
PMID: 38712319
PMC: 11073746.
DOI: 10.1093/braincomms/fcae141.
Bermejo-Pareja F, Del Ser T
J Clin Med. 2024; 13(2).
PMID: 38256670
PMC: 10816332.
DOI: 10.3390/jcm13020536.
Lin S, Leitao A, Fang S, Gu Y, Barber S, Gilliard-Telefoni R
Neurobiol Dis. 2023; 178:106010.
PMID: 36702318
PMC: 10754494.
DOI: 10.1016/j.nbd.2023.106010.
Okazawa H, Ikawa M, Tsujikawa T, Mori T, Makino A, Kiyono Y
Antioxidants (Basel). 2022; 11(5).
PMID: 35624886
PMC: 9138060.
DOI: 10.3390/antiox11051022.
The Cause of Alzheimer's Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress.
Decourt B, DSouza G, Shi J, Ritter A, Suazo J, Sabbagh M
Aging Dis. 2022; 13(1):37-60.
PMID: 35111361
PMC: 8782548.
DOI: 10.14336/AD.2021.0529.
Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
Lloyd G, Dhillon J, Gorion K, Riffe C, Fromholt S, Xia Y
Mol Neurodegener. 2021; 16(1):63.
PMID: 34503546
PMC: 8427941.
DOI: 10.1186/s13024-021-00486-9.
Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
Thal D, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R
Acta Neuropathol Commun. 2019; 7(1):178.
PMID: 31727169
PMC: 6854805.
DOI: 10.1186/s40478-019-0837-9.
α-synuclein in the pathophysiology of Alzheimer's disease.
Twohig D, Nielsen H
Mol Neurodegener. 2019; 14(1):23.
PMID: 31186026
PMC: 6558879.
DOI: 10.1186/s13024-019-0320-x.
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
Twohig D, Rodriguez-Vieitez E, Sando S, Berge G, Lauridsen C, Moller I
Acta Neuropathol Commun. 2018; 6(1):130.
PMID: 30477568
PMC: 6260771.
DOI: 10.1186/s40478-018-0624-z.
The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
Ferman T, Aoki N, Crook J, Murray M, Graff-Radford N, van Gerpen J
Alzheimers Dement. 2017; 14(3):330-339.
PMID: 29100980
PMC: 5899889.
DOI: 10.1016/j.jalz.2017.09.014.
Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology.
Ngolab J, Trinh I, Rockenstein E, Mante M, Florio J, Trejo M
Acta Neuropathol Commun. 2017; 5(1):46.
PMID: 28599681
PMC: 5466770.
DOI: 10.1186/s40478-017-0445-5.
Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology.
Adamowicz D, Roy S, Salmon D, Galasko D, Hansen L, Masliah E
J Neurosci. 2017; 37(7):1675-1684.
PMID: 28039370
PMC: 5320602.
DOI: 10.1523/JNEUROSCI.3047-16.2016.
Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease.
Mitolo M, Hamilton J, Landy K, Hansen L, Galasko D, Pazzaglia F
J Int Neuropsychol Soc. 2016; 22(6):609-19.
PMID: 27221597
PMC: 5802394.
DOI: 10.1017/S1355617716000436.
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration.
Walsh D, Selkoe D
Nat Rev Neurosci. 2016; 17(4):251-60.
PMID: 26988744
PMC: 6701169.
DOI: 10.1038/nrn.2016.13.
Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases.
Milisav I, Suput D, Ribaric S
Molecules. 2015; 20(12):22718-56.
PMID: 26694349
PMC: 6332363.
DOI: 10.3390/molecules201219865.
Heterogeneity of Regional Brain Atrophy Patterns Associated with Distinct Progression Rates in Alzheimer's Disease.
Byun M, Kim S, Park J, Yi D, Choe Y, Sohn B
PLoS One. 2015; 10(11):e0142756.
PMID: 26618360
PMC: 4664412.
DOI: 10.1371/journal.pone.0142756.
Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease.
Salmon D, Heindel W, Hamilton J, Filoteo J, Cidambi V, Hansen L
Neuropsychologia. 2015; 75:548-55.
PMID: 26184443
PMC: 4752828.
DOI: 10.1016/j.neuropsychologia.2015.07.014.
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease.
Jellinger K, Alafuzoff I, Attems J, Beach T, Cairns N, Crary J
Acta Neuropathol. 2015; 129(5):757-62.
PMID: 25778618
PMC: 4534004.
DOI: 10.1007/s00401-015-1407-2.
Genetic Variants and Related Biomarkers in Sporadic Alzheimer's Disease.
Guerreiro R, Bras J, Toombs J, Heslegrave A, Hardy J, Zetterberg H
Curr Genet Med Rep. 2015; 3:19-25.
PMID: 25664224
PMC: 4317514.
DOI: 10.1007/s40142-014-0062-6.